A randomized controlled trial demonstrated that administration of d-chiro-inositol in combination with myo-inositol in 50 overweight females with polycystic ovary syndrome improved the metabolic parameters effectively. The researchers mentioned that this combination is able to reduce the metabolic and clinical alteration of polycystic ovary syndrome and thus can decrease the risk of metabolic disease.